KRN7000

alpha-galactosylceramide

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for KRN7000, covering 2006-07-14 to 2012-07-11. Get the full timeline:

Most recent: Clinical Trial Update: KRN7000 in Treating Patients With Solid Tumors [Phase 1]